About
Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organophosphate antidotes; ammonium, phosphonium; quats, phosphoranes, and wittig reagents; cholesterol and lanolin-related products; sterile injectables; and softgel formulations, as well as hand and body wash, sanitisers, and antiseptics. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
Key Metrics
as of Sep 2026Market Cap2,734 Cr
P/E151.00
Div Yield0.00 %
Book Value₹426.00
52w High₹322.00
52w Low₹128.00
Face Value₹2.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 57.00 | 69.00 | 40.00 | 60.00 | 63.00 | 106.00 | 97.00 | 93.00 | 103.00 | 111.00 | 87.00 | 60.00 | 70.00 |
| Expenses | 69.00 | 68.00 | 43.00 | 56.00 | 59.00 | 86.00 | 74.00 | 80.00 | 89.00 | 100.00 | 84.00 | 63.00 | 75.00 |
| Operating Profit | -12.00 | 1.00 | -4.00 | 4.00 | 3.00 | 21.00 | 23.00 | 13.00 | 15.00 | 12.00 | 3.00 | -3.00 | -5.00 |
| OPM % | -21.00 | 1.40 | -9.00 | 7.00 | 5.00 | 19.00 | 24.00 | 14.00 | 14.00 | 10.00 | 3.60 | -4.90 | -7.00 |
| Other Income | 17.00 | 29.00 | 7.00 | 11.00 | 37.00 | 5.00 | -8.00 | 24.00 | 12.00 | -3.00 | 13.00 | 36.00 | 14.00 |
| Depreciation | 15.00 | 15.00 | 15.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 26.00 | 26.00 | 25.00 | 25.00 |
| Interest | 22.00 | 22.00 | 24.00 | 21.00 | 20.00 | 21.00 | 18.00 | 16.00 | 16.00 | 16.00 | 17.00 | 17.00 | 18.00 |
| Profit before tax | -32.00 | -7.00 | -35.00 | -21.00 | 4.00 | -11.00 | -19.00 | 5.00 | -6.00 | -34.00 | -27.00 | -9.00 | -33.00 |
| Tax % | -25.00 | -42.00 | -34.00 | -35.00 | 35.00 | -35.00 | -31.00 | -162.00 | -38.00 | -7.00 | -33.00 | -38.00 | -35.00 |
| Net Profit | -24.00 | -4.00 | -23.00 | -14.00 | 3.00 | -7.00 | -13.00 | 14.00 | -3.00 | -31.00 | -18.00 | -6.00 | -21.00 |
| EPS in Rs | -1.53 | -0.28 | -1.48 | -0.87 | 0.17 | -0.47 | -0.85 | 0.91 | -0.22 | -1.98 | -1.16 | -0.37 | -1.36 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 232.00 | 400.00 | 327.00 | 403.00 | 307.00 | 200.00 | 581.00 | 549.00 | 474.00 | 451.00 | 7.00 | 0.00 |
| Expenses | 226.00 | 328.00 | 321.00 | 394.00 | 267.00 | 253.00 | 401.00 | 356.00 | 308.00 | 303.00 | 5.00 | 0.00 |
| Operating Profit | 5.00 | 72.00 | 7.00 | 9.00 | 40.00 | -53.00 | 179.00 | 194.00 | 166.00 | 148.00 | 2.00 | 0.00 |
| OPM % | 2.30 | 18.00 | 2.10 | 2.20 | 13.00 | -26.00 | 31.00 | 35.00 | 35.00 | 33.00 | 25.00 | — |
| Other Income | 85.00 | 33.00 | 60.00 | 49.00 | 53.00 | 59.00 | 64.00 | 72.00 | 66.00 | 71.00 | 0.00 | 0.00 |
| Interest | 87.00 | 70.00 | 68.00 | 58.00 | 37.00 | 34.00 | 47.00 | 47.00 | 35.00 | 39.00 | 1.00 | 1.00 |
| Depreciation | 63.00 | 65.00 | 102.00 | 96.00 | 140.00 | 141.00 | 141.00 | 136.00 | 134.00 | 136.00 | 0.00 | 0.00 |
| Profit before tax | -59.00 | -31.00 | -103.00 | -96.00 | -84.00 | -169.00 | 55.00 | 82.00 | 62.00 | 44.00 | 1.00 | 0.00 |
| Tax % | -35.00 | -68.00 | -26.00 | -39.00 | -63.00 | 38.00 | 31.00 | 31.00 | 40.00 | 45.00 | 12.00 | 0.00 |
| Net Profit | -38.00 | -10.00 | -76.00 | -59.00 | -32.00 | -233.00 | 39.00 | 56.00 | 37.00 | 24.00 | 1.00 | 0.00 |
| EPS in Rs | -2.45 | -0.63 | -4.87 | -3.75 | -2.01 | -14.85 | 2.46 | 3.47 | 2.30 | — | — | — |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 31.00 | 32.00 | 32.00 | 0.00 | 0.05 | 0.05 |
| Reserves | 3,851.00 | 3,999.00 | 4,021.00 | 4,083.00 | 4,200.00 | 4,643.00 | 4,764.00 | 4,860.00 | 4,759.00 | 4,771.00 | 0.00 | -1.00 |
| Borrowings | 634.00 | 686.00 | 536.00 | 593.00 | 535.00 | 538.00 | 573.00 | 584.00 | 622.00 | 445.00 | 9.00 | 10.00 |
| Other Liabilities | 610.00 | 405.00 | 488.00 | 473.00 | 448.00 | 339.00 | 366.00 | 339.00 | 394.00 | 321.00 | 3.00 | 3.00 |
| Total Liabilities | 5,126.00 | 5,122.00 | 5,077.00 | 5,181.00 | 5,214.00 | 5,552.00 | 5,735.00 | 5,816.00 | 5,807.00 | 5,537.00 | 12.00 | 12.00 |
| Fixed Assets | 1,372.00 | 1,401.00 | 1,416.00 | 1,382.00 | 1,356.00 | 1,510.00 | 1,633.00 | 1,715.00 | 1,853.00 | 1,927.00 | 0.00 | 0.00 |
| CWIP | 23.00 | 41.00 | 74.00 | 143.00 | 118.00 | 121.00 | 89.00 | 70.00 | 48.00 | 41.00 | 0.00 | 0.00 |
| Investments | 2,844.00 | 2,841.00 | 2,848.00 | 2,913.00 | 3,032.00 | 2,882.00 | 2,900.00 | 2,907.00 | 2,937.00 | 2,761.00 | 0.00 | 0.00 |
| Other Assets | 887.00 | 840.00 | 739.00 | 743.00 | 708.00 | 1,039.00 | 1,113.00 | 1,124.00 | 969.00 | 808.00 | 12.00 | 12.00 |
| Total Assets | 5,126.00 | 5,122.00 | 5,077.00 | 5,181.00 | 5,214.00 | 5,552.00 | 5,735.00 | 5,816.00 | 5,807.00 | 5,537.00 | 12.00 | 12.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 46.00 | 56.00 | 24.00 | -53.00 | 227.00 | -2.00 | 197.00 | 120.00 | 20.00 | 270.00 | 3.00 | -1.00 |
| Cash from Investing Activity | 22.00 | -80.00 | 97.00 | 41.00 | -173.00 | 62.00 | -74.00 | -24.00 | -175.00 | -16.00 | 0.00 | 0.00 |
| Cash from Financing Activity | -120.00 | 88.00 | -131.00 | 1.00 | -46.00 | -71.00 | -124.00 | -85.00 | 142.00 | -225.00 | -2.00 | 1.00 |
| Net Cash Flow | -52.00 | 64.00 | -10.00 | -11.00 | 9.00 | -10.00 | -2.00 | 10.00 | -12.00 | 29.00 | 1.00 | 0.00 |
| Free Cash Flow | 19.00 | 2.00 | -12.00 | -175.00 | 190.00 | -48.00 | 126.00 | 78.00 | -55.00 | 170.00 | 3.00 | -1.00 |
| CFO/OP % | 914.00 | 81.00 | 373.00 | -556.00 | 591.00 | -11.00 | 120.00 | 72.00 | 27.00 | 208.00 | 160.00 | 13,100.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 269.00 | 160.00 | 205.00 | 133.00 | 78.00 | 217.00 | 91.00 | 86.00 | 108.00 | 58.00 | 0.00 |
| Inventory Days | 1,440.00 | 374.00 | 534.00 | 389.00 | 723.00 | 690.00 | 390.00 | 500.00 | 397.00 | 390.00 | — |
| Days Payable | 699.00 | 201.00 | 365.00 | 182.00 | 198.00 | 204.00 | 157.00 | 210.00 | 207.00 | 149.00 | — |
| Cash Conversion Cycle | 1,010.00 | 333.00 | 374.00 | 340.00 | 604.00 | 703.00 | 324.00 | 376.00 | 298.00 | 298.00 | 0.00 |
| Working Capital Days | -342.00 | -74.00 | -62.00 | -123.00 | -111.00 | 82.00 | 14.00 | 95.00 | 90.00 | 71.00 | 467.00 |
| ROCE % | 1.00 | 1.00 | -1.00 | -1.00 | -1.00 | -2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 21.00 |
Corporate Actions
1 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Dividend | 12 Sep 2019 | — | — | 0.20 |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update4 Jun from fitch
-
Rating update18 Feb from fitch
-
Rating update15 Apr 2025 from fitch
-
Rating update16 Apr 2024 from fitch
-
Rating update16 Apr 2024 from fitch
-
Rating update11 Jan 2024 from fitch
Conference Calls
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript